- Country: Brazil
- Summary: Price Registration for the Acquisition of Permap 100/2025 Medicines
- BRT Ref No: 125321543
- Deadline: 30 Sep 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 90100/2025
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Object: Electronic Auction - Price Record for PERP 100/2025 Medicines Purchase
08:00 to 12:00 and from 13:00 to 17:59
Proposal Delivery: From 08/28/2025 to 08:00
Dexlansoprazole, concentration 60 mg,ccb25dd379407458d1bf3bd9c3c3eda6 Character Additional Prolonged Release
4202856
51056
FORMOTEROL Fumarato, composition associated with Budesonide, 12 mcg + 400mcg/dose concentration, pharmaceutical form inhalation, additional features with inhaler vial
Sulfate, concentration 30mg
Dosage 95%, Adult Suppository Presentation
8611 - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINPrice Registration for the Acquisition of Permap 100/2025 Medicines - Brazil Tender
The SAO PAULO STATE GOVERNMENT, a Government sector organization in Brazil, has announced a new tender for Price Registration for the Acquisition of Permap 100/2025 Medicines. This tender is published on BrazilTenders under BRT Ref No: 125321543 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-09-30.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
